Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -92,287 | -62,734 | -44,206 | -20,653 | -50,463 |
| Depreciation Amortization | 50 | 23 | 13 | 6 | 27 |
| Accounts payable and accrued liabilities | 3,526 | 3,370 | -1,191 | -1,739 | 1,528 |
| Other Working Capital | 5,781 | 996 | -2,274 | -1,623 | -2,366 |
| Other Operating Activity | 7,373 | 5,233 | 7,492 | 2,951 | 2,708 |
| Operating Cash Flow | $-75,557 | $-53,112 | $-40,166 | $-21,058 | $-48,566 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35,307 | -9,685 | -1,934 | -505 | -8,564 |
| Investing Cash Flow | $-35,307 | $-9,685 | $-1,934 | $-505 | $-8,564 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 212,487 | 168,720 | 130,759 | 108,710 | 118,503 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 4,602 |
| Financing Cash Flow | $212,487 | $168,720 | $130,759 | $108,710 | $123,105 |
| Exchange Rate Effect | -31 | -21 | -8 | -1 | -16 |
| Beginning Cash Position | 77,308 | 77,308 | 77,308 | 77,308 | 11,349 |
| End Cash Position | 178,900 | 183,210 | 165,959 | 164,454 | 77,308 |
| Net Cash Flow | $101,592 | $105,902 | $88,651 | $87,146 | $65,959 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,557 | -53,112 | -40,166 | -21,058 | -48,566 |
| Capital Expenditure | -35,307 | -9,685 | -1,934 | -505 | -8,564 |
| Free Cash Flow | -110,864 | -62,797 | -42,100 | -21,563 | -57,130 |